Hong-wei Guo

Hong-wei Guo


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2023 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
SCShu-Gang Cui
Shu-Gang Cui
YZYu-Ling Zhang
Yu-Ling Zhang
HGHong-wei Guo
Hong-wei Guo
BZBian-Hua Zhou
Bian-Hua Zhou
ETErjie Tian
Erjie Tian
HWHongwei Wang
Hongwei Wang

19 January 2021 in Research Square
Verified
Preprint
Open access
PDF file
BZBian-Hua Zhou
Bian-Hua Zhou
HDHai-Yan Ding
Hai-Yan Ding
JYJing-Yun Yang
Jing-Yun Yang
JCJun Chai
Jun Chai
HGHong-wei Guo
Hong-wei Guo
ETErjie Tian
Erjie Tian
Background: Diclazuril is a classic anticoccidial drug. The key molecules of diclazuril in anticoccidial action allows target screening for the development of anticoccidial drugs. In the present study, a diclazuril anticoccidiosis animal model was established, and the transcription and translation levels of the CDK-related kinase 2 of Eimeria tenella (EtCRK2) were detected through quantitative real-time PCR and Western blot analysis, respectively. The localisation of EtCRK2 in merozoites was examined with immunofluorescence techniques.Results: The mRNA and protein expression levels of EtCRK2 decreased in the infected/diclazuril group compared with those in the infected/control group. In addition, immunofluorescence analysis showed that EtCRK2 was localised in the cytoplasm of the merozoites. The fluorescence intensity of EtCRK2 in the infected/diclazuril group was significantly weaker than that in the infected/control group.Conclusions: The anticoccidial drug diclazuril against E.tenella affects the expression pattern of EtCRK2 molecule, and EtCRK2 is a potential target for new drug development.